Afficher la couverture 'EFFECTS OF PATISIRAN, AN RNA INTERFERENCE THERAPEUTIC, ON REGIONAL LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: THE APOLLO STUDY | Minamisawa, Masatoshi' en grand format
/5

0 avis

EFFECTS OF PATISIRAN, AN RNA INTERFERENCE THERAPEUTIC, ON REGIONAL LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: THE APOLLO STUDY

Archive ouverte

Minamisawa, Masatoshi | Adams, David | Kristen, Arnt | Merlini, Giampaolo | Slama, Michel | Dispenzieri, Angela | Falk, Rodney H. | Karsten, Verena | Sweetser, Marianne | Chen, Jihong | Riese, Richard | Vest, John | Solomon, Scott

Edité par CCSD ; Elsevier -

68th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), New Orleans, LA, MAR 16-18, 2019. International audience

Consulter en ligne

Suggestions

Du même auteur

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis The APOLLO Study

Archive ouverte | Minamisawa, Masatoshi | CCSD

International audience. IMPORTANCE Patients with cardiac amyloidosis demonstrate reduced myocardial strain with associated sparing of the cardiac apex. In the APOLLO randomized clinical trial, patisiran, an RNA inte...

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Archive ouverte | Maurer, Mathew | CCSD

International audience. Background: Transthyretin amyloidosis, also called ATTR amyloidosis, is associated with accumulation of ATTR amyloid deposits in the heart and commonly manifests as progressive cardiomyopathy...

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

Archive ouverte | Adams, David | CCSD

International audience. BACKGROUND : Hereditary transthyretin-mediated amyloidosis is a rare, inherited, progressive disease caused by mutations in the transthyretin (TTR) gene. We assessed the safety and efficacy o...

Chargement des enrichissements...